Rocky Mountain Advisers, LLC Connect Biopharma Holdings LTD Transaction History
Rocky Mountain Advisers, LLC
- $121 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding CNTB
# of Institutions
17Shares Held
3.28MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.86 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$454,5230.04% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$143,1710.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$119,8800.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$92,4620.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $49M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...